[HTML][HTML] Evidence-based treatment options in recurrent and/or metastatic squamous cell carcinoma of the head and neck
A Argiris, KJ Harrington, M Tahara, J Schulten… - Frontiers in …, 2017 - frontiersin.org
The major development of the past decade in the first-line treatment of recurrent and/or
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …
metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) was the …
Signaling pathways in HPV‐associated cancers and therapeutic implications
J Chen - Reviews in medical virology, 2015 - Wiley Online Library
Human papillomaviruses (HPVs) are small double‐stranded circular DNA viruses with 8 kb
genomes. So far, more than 150 HPVs have been identified, and 12 types of HPVs have …
genomes. So far, more than 150 HPVs have been identified, and 12 types of HPVs have …
[PDF][PDF] Targeting BMI1+ cancer stem cells overcomes chemoresistance and inhibits metastases in squamous cell carcinoma
Squamous cell carcinoma in the head and neck (HNSCC) is a common yet poorly
understood cancer, with adverse clinical outcomes due to treatment resistance, recurrence …
understood cancer, with adverse clinical outcomes due to treatment resistance, recurrence …
FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma
The fibroblast growth factor 19 gene FGF19 has previously been reported to be amplified in
several cancer types and encodes for a key autocrine signaler known to promote …
several cancer types and encodes for a key autocrine signaler known to promote …
[HTML][HTML] Cigarette smoke containing acrolein upregulates EGFR signaling contributing to oral tumorigenesis in vitro and in vivo
HH Tsou, HC Tsai, CT Chu, HW Cheng, CJ Liu… - Cancers, 2021 - mdpi.com
Simple Summary Oral squamous cell carcinoma (OSCC) is one of the most common
smoking-related cancer types in the world. Better understanding of the pathophysiology of …
smoking-related cancer types in the world. Better understanding of the pathophysiology of …
Increase of intracellular cisplatin levels and radiosensitization by ultrasound in combination with microbubbles
BHA Lammertink, C Bos… - Journal of controlled …, 2016 - Elsevier
The possibility to enhance drug delivery by using ultrasound in combination with
microbubbles (USMB) is extensively studied. So far, these studies have focused on the …
microbubbles (USMB) is extensively studied. So far, these studies have focused on the …
Real-world treatment outcomes of the EXTREME regimen as first-line therapy for recurrent/metastatic squamous cell carcinoma of the head and neck: a multi-center …
D Sano, T Fujisawa, M Tokuhisa, M Shimizu… - Anticancer …, 2019 - ar.iiarjournals.org
Background/Aim: This Japanese multiple-center retrospective study aimed to examine the
real-world treatment outcomes of the EXTREME regimen as a first-line therapy for …
real-world treatment outcomes of the EXTREME regimen as a first-line therapy for …
Identification of PSMD7 as a prognostic factor correlated with immune infiltration in head and neck squamous cell carcinoma
S Zhang, S Yu, J Wang, Z Cheng - Bioscience Reports, 2021 - portlandpress.com
Background: Recurrent locally advanced or metastatic head and neck squamous cell
carcinoma (HNSCC) is associated with dismal prognosis because of its highly invasive …
carcinoma (HNSCC) is associated with dismal prognosis because of its highly invasive …
[HTML][HTML] Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line …
R Depenni, MC Rocca, D Ferrari, G Azzarello… - European Journal of …, 2019 - Elsevier
Aim The aims of the study are to evaluate the clinical outcomes of first-line treatment with
platinum-based chemotherapy and cetuximab in patients with relapsing/metastatic head and …
platinum-based chemotherapy and cetuximab in patients with relapsing/metastatic head and …
[HTML][HTML] Survival predictors and outcomes of patients with recurrent and/or metastatic head and neck cancer treated with chemotherapy plus cetuximab as first-line …
F Pontes, AR Garcia, I Domingues, MJ Sousa… - Cancer Treatment and …, 2021 - Elsevier
Background In patients with recurrent or metastatic head and neck squamous cell carcinoma
(R/M HNSCC) the estimated prognosis is usually poor. Patient-specific factors that affect …
(R/M HNSCC) the estimated prognosis is usually poor. Patient-specific factors that affect …